Marshall Financial Group (Maryland)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Sell |
512
-136
| -21% | -$62.5K | 0.05% | 233 |
|
|
2025
Q1 | $314K | Sell |
648
-312
| -33% | -$151K | 0.07% | 190 |
|
|
2024
Q4 | $387K | Sell |
960
-3,963
| -80% | -$1.6M | 0.09% | 159 |
|
|
2024
Q3 | $2.29M | Sell |
4,923
-88
| -2% | -$40.9K | 0.55% | 43 |
|
|
2024
Q2 | $2.35M | Buy |
5,011
+176
| +4% | +$82.5K | 0.66% | 38 |
|
|
2024
Q1 | $2.02M | Buy |
4,835
+168
| +4% | +$70.2K | 0.58% | 44 |
|
|
2023
Q4 | $1.9M | Sell |
4,667
-55
| -1% | -$22.4K | 0.61% | 44 |
|
|
2023
Q3 | $1.64M | Buy |
4,722
+39
| +0.8% | +$13.6K | 0.59% | 49 |
|
|
2023
Q2 | $1.65M | Buy |
4,683
+132
| +3% | +$46.5K | 0.56% | 49 |
|
|
2023
Q1 | $1.43M | Buy |
4,551
+79
| +2% | +$24.9K | 0.51% | 52 |
|
|
2022
Q4 | $1.29M | Buy |
+4,472
| New | +$1.29M | 0.5% | 63 |
|